PILLARS OF GROWTH

VCC MEDICAL DIVISION IS DEVELOPING CLINICALLY PROVEN PRODUCTS, SHOWN TO MAINTAIN REMISSION AND ALLEVIATE DISEASE

VCC-001 cancer vaccine Phase III data in Renal Cell Cancer has demonstrated clinical effect and was well tolerated, a disease with few current treatment options

VCC-001 cancer vaccine concept has significant potential in colon and pancreatic cancers

DE-RISKED BY REVENUE FROM MARKETED PRODUCTS IN PERSONALIZED MEDICINE DIVISION AND GMP CERTIFIED MANUFACTURING AND PRODUCTION SITE FBM-PHARMA

Leadership team &

Board of directors

Dr. Matthias Oertle
Chairman of the Board of Directors

Marcel Frei
Director

Dr. Pierre Pellier
Director

Suphasis Roy
Director

Martin Munte
Chief Executive Officer | Delegate of the Board of Directors

Dr. Ingrid Rauter
Head of R&D and Chief Medical Officer

Dr. Peter Linder
Head of Quality Control, FBM-Pharma

Helge Roenau
Managing Director of FBM-Pharma and VCC Medical

Heinz Studer
Chief Operating Officer